146 related articles for article (PubMed ID: 22156406)
1. Prognostic value of NT-proBNP at rest and peak exercise in patients with impaired left ventricular function.
Kallistratos MS; Pavlidis AN; Chamodraka ES; Varounis C; Dritsas A; Laoutaris ID; Manolis AJ; Cokkinos DV
Angiology; 2012 Oct; 63(7):516-21. PubMed ID: 22156406
[TBL] [Abstract][Full Text] [Related]
2. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
3. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
4. Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2008 Nov; 27(11):1251-6. PubMed ID: 18971099
[TBL] [Abstract][Full Text] [Related]
5. Exercise oscillatory breathing and NT-proBNP levels in stable heart failure provide the strongest prediction of cardiac outcome when combining biomarkers with cardiopulmonary exercise testing.
Guazzi M; Boracchi P; Labate V; Arena R; Reina G
J Card Fail; 2012 Apr; 18(4):313-20. PubMed ID: 22464773
[TBL] [Abstract][Full Text] [Related]
6. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
[TBL] [Abstract][Full Text] [Related]
7. No incremental clinical information of NT Pro BNP at peak exercise over resting levels in patients with impaired left ventricular function.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
Int J Cardiol; 2007 Oct; 121(2):221-3. PubMed ID: 17145088
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
Giallauria F; Cirillo P; Lucci R; Pacileo M; De Lorenzo A; D'Agostino M; Moschella S; Psaroudaki M; Del Forno D; Orio F; Vitale DF; Chiariello M; Vigorito C
Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196
[TBL] [Abstract][Full Text] [Related]
11. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J; Svensson SE
Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
[TBL] [Abstract][Full Text] [Related]
13. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
[TBL] [Abstract][Full Text] [Related]
14. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
[TBL] [Abstract][Full Text] [Related]
15. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.
Tschöpe C; Kasner M; Westermann D; Gaub R; Poller WC; Schultheiss HP
Eur Heart J; 2005 Nov; 26(21):2277-84. PubMed ID: 16014646
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
[TBL] [Abstract][Full Text] [Related]
17. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
Nguyen TH; Neil CJ; Sverdlov AL; Mahadavan G; Chirkov YY; Kucia AM; Stansborough J; Beltrame JF; Selvanayagam JB; Zeitz CJ; Struthers AD; Frenneaux MP; Horowitz JD
Am J Cardiol; 2011 Nov; 108(9):1316-21. PubMed ID: 21871590
[TBL] [Abstract][Full Text] [Related]
19. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
[TBL] [Abstract][Full Text] [Related]
20. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]